81419

Gene analysis panel for evaluation of genes associated with epilepsy

Medicare pricing data for 36 providers across 8 states

🤖AI Overview

This is a specialized procedure with relatively few Medicare claims. Pricing data may be less reliable due to smaller sample sizes. Note: These costs reflect the Medicare physician/supplier component. Hospital facility fees are billed separately and can be 2-5x the physician fee.

💡 What You Should Know

Gene analysis panel for evaluation of genes associated with epilepsy (HCPCS code 81419) is a medical procedure billed to Medicare. The average Medicare-allowed cost is $2,400, but hospitals typically charge $3,241 — a 1.4x markup. Prices vary significantly by state and provider.

🏷️ Typical Out-of-Pocket Cost

$479.92

Medicare patients typically pay about 20% of the allowed amount as coinsurance. Based on the average allowed cost of $2,400, your out-of-pocket cost would be approximately $479.92. Actual costs depend on your specific plan, deductible, and whether you've met your annual out-of-pocket maximum.

Average Allowed Cost
$2,400
Average Hospital Charge
$3,241
Markup Ratio
1.4x

What Hospitals Charge vs. What Medicare Pays

Hospital Charge$3,241.25
Medicare Allowed$2,399.59
Medicare Payment$2,399.59

Hospitals charge 1.4x more than what Medicare allows for this procedure. Medicare actually pays $2,400 on average.

Cost by State

Medicare-allowed amounts vary significantly by state

StateAllowed CostHospital ChargeProvidersServicesvs. National
Florida$2,400$3,185111,8100.0%
Louisiana$2,400$2,5541520.0%
Maryland$2,400$4,9001140.0%
New Jersey$2,400$3,67221,3020.0%
Oklahoma$2,400$3,42135340.0%
Texas$2,400$2,952152,2470.0%
Arizona$2,400$3,0001440.0%
Colorado$2,400$4,9812690.0%

⚠️ Important: These costs reflect the Medicare physician/supplier component. Hospital facility fees may be billed separately. Total out-of-pocket costs may be higher.

Related from TheDataProject.ai

💊 Need post-procedure medications? Check costs on OpenPrescriber